REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Eli Lilly (Phils.) Inc. (Philippines)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Eli Lilly (Phils.) Inc. Profile Updated: December 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The subject is engaged with instituting, entering into, assisting, conducting, performing, carrying on, or participating in commercial, manufacturing, mercantile, industrial, or wholesale pharmaceutical or drug enterprises, businesses, contracts, undertakings, ventures, or operations.

Headquarters
Units 401-403, Tower 1, Rockwell Business Center, Ortigas Avenue
Pasig; National Capital Region; Postal Code: 1605

Contact Details: Purchase the Eli Lilly (Phils.) Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Eli Lilly (Phils.) Inc. report to view the information.
Incorporation Date:
January 01, 1961
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Eli Lilly (Phils.) Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
-21.63%▼
Total operating revenue
-21.63%▼
Operating profit (EBIT)
-21.63%▼
EBITDA
-21.63%▼
Net Profit (Loss) for the Period
N/A
Total Assets
-0.98%▼
Total Equity
4.15%▲
Operating Profit Margin (ROS)
0%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
105.64%▲
Cash Ratio
105.02%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo